Oasil (Chlordiazepoxide Hydrochloride)

Chlordiazepoxide, the active ingredient in Oasil, is a benzodiazepine presented as an oral dosage form for oral use. It treats anxiety disorders, helps manage acute alcohol withdrawal, and provides sedation before medical procedures in adult patients. GNH USA supplies Oasil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chlordiazepoxide is a benzodiazepine that acts on the central nervous system to relieve anxiety‑related conditions and facilitate sedation. - Anxiety disorders: reduces excessive worry and tension in patients with generalized anxiety. - Acute alcohol withdrawal: alleviates tremor, agitation, and risk of seizures during early detoxification. - Sedation before medical procedures: provides calming and amnestic effects for minor surgeries or diagnostic tests.

Chlordiazepoxide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness - Dizziness - Fatigue - Blurred vision - Impaired coordination - Short‑term memory impairment

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Paradoxical agitation or aggression - Physical dependence and withdrawal syndrome - Seizures upon abrupt discontinuation - Hepatic dysfunction or jaundice

Before prescribing chlordiazepoxide, clinicians should consider several safety factors. - Evaluate respiratory status: patients with COPD or sleep apnea may be at increased risk. - Review hepatic function: impaired metabolism can raise drug concentrations. - Assess for substance dependence: risk of tolerance and dependence with prolonged use. - Use caution in elderly: heightened sensitivity to sedative effects. - Avoid concurrent CNS depressants: may potentiate sedation and respiratory depression. - Store at room temperature: keep below 25°C in original container, protect from moisture.

Chlordiazepoxide can interact with other medications, altering its efficacy or safety.

Major Interactions (Avoid): - Alcohol: additive CNS depression and increased sedation. - Opioids: heightened risk of respiratory depression and profound sedation. - Barbiturates: synergistic depressant effects on the central nervous system. - Other benzodiazepines: excessive sedation and cumulative respiratory depression. - Antihistamines: increased drowsiness and impaired psychomotor performance. - CNS depressants: amplified sedative and respiratory effects.

Moderate Interactions (Monitor Closely): - SSRIs and other antidepressants: may increase sedation. - Anticonvulsants (e.g., carbamazepine): can alter chlordiazepoxide metabolism. - CYP3A4 inhibitors (e.g., erythromycin): may raise plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce effectiveness. - Oral contraceptives: potential for altered hormone levels.